Back to GEN Stock Lookup
Pages: 1 2 3 »» Last Page

Genesis HealthCare (GEN) – Company Press Releases

Apr 29, 2016 10:43 AM Genesis HealthCare To Release First Quarter 2016 Results On May 9, 2016
Apr 27, 2016 08:00 AM GeneNews Issues MCTO Update
Apr 20, 2016 10:53 AM Genmab Announces Daratumumab Data to be Presented at 2016 ASCO Annual Meeting
Apr 20, 2016 01:08 AM Genmab Updates Financial Guidance for 2016
Apr 12, 2016 07:14 PM GeneNews Provides Default Status Report
Apr 7, 2016 04:02 PM Genesis Healthcare Names Richard A. Feifer, MD, MPH, FACP As Chief Medical Officer Of Its Physician Subsidiary
Apr 4, 2016 02:10 PM Patent Infringement Lawsuit Filed Against Genmab and Janssen in the United States Regarding DARZALEX(r)
Apr 1, 2016 11:46 AM CHMP Issues Positive Opinion Recommending DARZALEX(r) (daratumumab) for Relapsed and Refractory Multiple Myeloma
Mar 31, 2016 08:30 AM GeneNews and JTS Health Partners Establish Innovative Approach to Cancer Diagnostics Through Business Acceleration Agreement
Mar 30, 2016 12:19 PM Genmab Announces Positive Interim Result in Phase III Castor Study of Daratumumab in Relapsed or Refractory Multiple Myeloma
Mar 29, 2016 08:57 AM GeneNews Announces Granting of Management Cease Trade Order
Mar 21, 2016 01:22 PM Genmab Announces Studies of Daratumumab in Combination with Atezolizumab in a Solid Tumor and Multiple Myeloma
Mar 17, 2016 01:54 PM Constitution of the Board of Directors in Genmab A/S and Grant of Warrants to Employees in Genmab
Mar 17, 2016 07:30 AM GeneNews Files Management Cease Trade Order
Mar 16, 2016 08:42 AM GeneNews Announces Extension of TSX’s Remedial Review Process
Mar 14, 2016 02:27 PM GeneNews Limited Announces Private Placement Financing of up to $5 Million
Mar 11, 2016 07:30 AM GeneNews Applies For Extension of TSX’s Remedial Review Process
Mar 10, 2016 03:01 PM Genmab Announces Submission of Supplemental Biologics License Application to FDA for Ofatumumab in Combination with Fludarabine and Cyclophosphamide for Relapsed CLL
Mar 10, 2016 01:57 PM Genesis HealthCare to Present at the Barclays Global Healthcare Conference on March 16, 2016
Mar 9, 2016 02:21 PM Genmab Achieves Second Milestone in Daratumumab NHL Study Under Collaboration with Janssen
Mar 9, 2016 11:03 AM Genmab Announces European Regulatory Submission for Ofatumumab in Combination with Fludarabine and Cyclophosphamide for Relapsed CLL
Mar 9, 2016 08:30 AM Genesis HealthCare Signs Agreement To Sell Home Health And Hospice Operations
Mar 8, 2016 02:16 AM Genmab Provides Update on Ofatumumab Development in Autoimmune Indications
Mar 4, 2016 07:30 AM GeneNews Acquires Full Control of Innovative Diagnostic Laboratory
Feb 22, 2016 09:00 PM Genesis HealthCare Reports Fourth Quarter And Fiscal Year End 2015 Results
Feb 17, 2016 11:10 AM Genmab 2015 Annual Report
Feb 10, 2016 02:32 PM Genesis Healthcare Raises Nearly $255,000 As Gold National Team For Alzheimer's Association Walk To End Alzheimer's®
Feb 4, 2016 06:32 PM Major Shareholder Announcement
Feb 4, 2016 10:48 AM New hospitals and health care providers join successful, cutting-edge federal initiative that cuts costs and puts patients at the center of their care
Feb 2, 2016 01:00 AM Medicxi Ventures, Formerly Index Ventures Life Sciences, Launches as an Independent Venture Capital Firm and Announces Closing of a €210m Fund including GSK and Johnson & Johnson Innovation
Jan 25, 2016 08:30 AM Genesis Healthcare Announces Preliminary 2016 Growth Outlook And Adjusts 2015 Guidance
Jan 19, 2016 03:25 PM Genmab Announces U.S. FDA Approval of Arzerra(r) (ofatumumab) as Extended Treatment for Recurrent or Progressive CLL
Jan 18, 2016 04:45 PM GeneNews Announces Notification of TSX Continued Listing Review
Jan 11, 2016 04:13 PM Genesis Rehab Services and Apollo Education Group to Accelerate Health Care Workforce Training in China
Jan 4, 2016 08:30 AM Genesis HealthCare Divests Vintage Park Assisted Living Properties In Kansas
Dec 21, 2015 12:08 PM Genmab Achieves $3 Million Milestone in DuoBody Platform Collaboration with Janssen
Dec 18, 2015 09:08 AM Genmab Achieves $3 Million Milestone for Progress in DuoBody Platform Collaboration with Janssen
Dec 9, 2015 09:56 AM Genmab Achieves USD 5 Million Milestone in Daratumumab Collaboration with Janssen
Dec 7, 2015 08:00 AM GeneNews Provides Further Corporate Update
Dec 7, 2015 08:00 AM GeneNews Provides Further Corporate Update
Dec 3, 2015 10:42 AM Genesis HealthCare to Present at Oppenheimer's 26th Annual Healthcare Conference
Dec 1, 2015 12:28 PM Genesis HealthCare Completes Previously Announced Transaction With Revera Inc.
Nov 23, 2015 05:08 PM Genmab Announces Ofatumumab Phase III Study in Follicular Lymphoma to be Stopped Following Planned Interim Analysis
Nov 19, 2015 06:14 PM Genmab Achieves USD 45 Million Milestone in DARZALEX(TM) (daratumumab) Collaboration With Janssen
Nov 17, 2015 11:38 AM Major Shareholder Announcement
Nov 16, 2015 02:29 PM Genmab Announces U.S. FDA Approval of DARZALEX(TM) (daratumumab) for Multiple Myeloma and Updates Financial Guidance
Nov 13, 2015 08:30 AM GeneNews Announces Q3-2015 Financial Results and Provides Update
Nov 12, 2015 08:30 AM Genesis HealthCare Announces Value-Based Initiatives
Nov 9, 2015 04:46 PM Genesis HealthCare to Present at the Stephens Fall Investment Conference on November 10, 2015
Nov 5, 2015 04:03 PM Genesis HealthCare Reports Third Quarter 2015 Results
Pages: 1 2 3 »» Last Page

Back to GEN Stock Lookup